Intas Pharmaceuticals Limited (manufacturing of medicinal product, primary and secondary packaging, quality control of batch, export to batch release site)

The drug is used for adjuvant therapy of stage III colorectal cancer after complete tumor removal, as well as for the treatment of metastatic colorectal cancer (usually in combination with other drugs, such as 5-fluorouracil and folinic acid).

Dosage form: concentrate for infusion solution

ATC: L01XA03